[go: up one dir, main page]

AU7525496A - Methods and compositions comprising glut-2 and glut-2 chimeras - Google Patents

Methods and compositions comprising glut-2 and glut-2 chimeras

Info

Publication number
AU7525496A
AU7525496A AU75254/96A AU7525496A AU7525496A AU 7525496 A AU7525496 A AU 7525496A AU 75254/96 A AU75254/96 A AU 75254/96A AU 7525496 A AU7525496 A AU 7525496A AU 7525496 A AU7525496 A AU 7525496A
Authority
AU
Australia
Prior art keywords
glut
chimeras
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75254/96A
Inventor
Samuel A. Clark
Christopher B Newgard
Karl D. Normington
Anice E. Thigpen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Betagene Inc
University of Texas System
Original Assignee
Betagene Inc
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betagene Inc, University of Texas System, University of Texas at Austin filed Critical Betagene Inc
Publication of AU7525496A publication Critical patent/AU7525496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU75254/96A 1995-10-23 1996-10-23 Methods and compositions comprising glut-2 and glut-2 chimeras Abandoned AU7525496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54693495A 1995-10-23 1995-10-23
US546934 1995-10-23
PCT/US1996/017327 WO1997015668A2 (en) 1995-10-23 1996-10-23 Methods and compositions comprising glut-2 and glut-2 chimeras

Publications (1)

Publication Number Publication Date
AU7525496A true AU7525496A (en) 1997-05-15

Family

ID=24182621

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75254/96A Abandoned AU7525496A (en) 1995-10-23 1996-10-23 Methods and compositions comprising glut-2 and glut-2 chimeras

Country Status (3)

Country Link
EP (1) EP0857212A2 (en)
AU (1) AU7525496A (en)
WO (1) WO1997015668A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
WO2002043770A2 (en) * 2000-12-01 2002-06-06 Conforma Therapeutic Corporation Homing peptide multimers, their preparation and uses
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
EP1648926B1 (en) 2003-05-02 2013-07-03 Centre National De La Recherche Scientifique (Cnrs) Glut-1 as a receptor for htlv envelopes and its uses
EP1586650A1 (en) * 2004-04-16 2005-10-19 ProBioGen AG Intervention in the energy metabolism of eukaryotic cells for selection and increase of expression
JP2009504183A (en) 2005-08-15 2009-02-05 ジェネンテック・インコーポレーテッド Gene disruption and related compositions and methods
BRPI1007376B1 (en) 2009-01-09 2022-03-22 Centre National De La Recherche Scientifique New receptor-binding ligands and their use in the detection of cells of biological interest
CN118401659A (en) 2021-10-14 2024-07-26 阿西莫夫公司 Integrase, landing gear architecture and engineered cells comprising same
CN118696124A (en) 2021-11-09 2024-09-24 阿西莫夫公司 Stable production system for AAV vector production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358866A (en) * 1991-07-03 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Cytosine deaminase negative selection system for gene transfer techniques and therapies
US5366874A (en) * 1992-01-02 1994-11-22 Board Of Regents, The University Of Texas System Molecular cloning and expression of biologically-active diphtheria toxin receptor
CA2163427A1 (en) * 1993-05-21 1994-12-08 Stephen D. Lupton Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
WO1995000644A1 (en) * 1993-06-28 1995-01-05 Board Of Regents, The University Of Texas System Vectors for genetically engineered cells that produce insulin in response to glucose

Also Published As

Publication number Publication date
WO1997015668A2 (en) 1997-05-01
WO1997015668A3 (en) 1997-07-24
EP0857212A2 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU2230695A (en) Slag-based well cementing compositions and methods
AU3767097A (en) Shampoo compositions and method
AU7275098A (en) Enhanced adenovirus-assisted transfection composition and method
AU4266596A (en) Composition and use
AU3045395A (en) Cosmetic composition
AU3308195A (en) Antihypertriglyceridemic composition
AU2972597A (en) Compositions and uses thereof
AU4254596A (en) Cosmetic composition
AU2079397A (en) Improved connectors and methods
AU1466095A (en) Dermatologic composition
AU4542296A (en) Antimicrobic composition and its use
AUPO976597A0 (en) Method and composition (I)
AU9301998A (en) Composition and methods using galectin-1
AU4876397A (en) Insecticidal compositions and methods
AU7525496A (en) Methods and compositions comprising glut-2 and glut-2 chimeras
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU3200197A (en) New composition and methods
AUPN137895A0 (en) Composition and method
AU3634595A (en) Bis-oxazolidines and their use
AU1614495A (en) Chair
AU1129697A (en) Modified polyalkadiene-containing compositions
AUPO982097A0 (en) Methods and compositions for use therein